Livestream Course Options

Scottsdale, AZ US
November 7, 2024 to November 9, 2024

 


Chadi Ayoub, M.B.B.S., Ph.D.Joerg Herrmann, M.D.Carolyn M. Larsen, M.D.Lida A. Mina, M.D.Donald W. Northfelt, M.D., and Chris Ray, M.D. 

November 7 - 9, 2024 - Fairmont Scottsdale Princess - Scottsdale, Arizona

This course reviews the prevention, diagnosis, and management of cardiac and vascular diseases of cancer patients throughout the continuum of their care including heart failure, myocardial ischemia, hypertension, thromboembolism, and arrhythmia. The course is directed towards the spectrum of providers who care for cancer patients to enable them to recognize the cardiovascular risk of their patients and take action to minimize this risk. This includes physicians, advance practice providers, pharmacists, and nurses in cardiology, hematology-oncology, primary care, and hospital internal medicine. The course includes lectures from experts as well as interactive case-based and question and answer sessions.

 

Registration FeesEarly Bird
(On or before October, 7, 2024)
Full Price
(After October 7, 2024)
Livestream
M.D., D.O., Ph.D.$950$1,025$950
Allied Health, NP, PA, Retirees$850$925$850
Resident/Fellow$550$550$250
IC-OS Board Review$150$150$150

 

 

 

*NEW*  IC-OS Board Review Sessions.   During the optional sessions, IC-OS members will review board style questions with participants.  Participation in all board review sessions will offer 3.00 additional credit hours and requires separate registration.  The target audience is attendees who are considering registering for the IC-OS Cardio-Oncology Board Certification Exam (https://ic-os.org/board-certification-admin/) or any attendees who are interested in additional cardio-oncology education in a question and answer format.  

The objectives of the board review sessions are to:

  • Solidify knowledge gained throughout the course by reviewing board style questions and answers with cardio-oncology experts
  • Help prepare participants for the IC-OS Cardio-Oncology Board Certification certificate exam

Target Audience

This course is designed for general cardiologists, heart failure specialists, and advanced practice providers working in cardiology who either currently practice cardio-oncology or aim to expand their practice into the field to optimize the care of this patient population. The course is also designed for providers in hematology, oncology, and internal medicine as they are often the first to encounter and diagnose patients with cardiotoxicity related to cancer therapies.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Develop an approach to the prevention and management of cancer therapeutics related cardiotoxicity.
  • Summarize guideline based cardiovascular surveillance during cancer therapy associated with a risk of cardiovascular toxicity.
  • Identify an approach to the integration of multimodality imaging into the cardio-oncology practice.
  • Review advances in the management of TTR and AL cardiac amyloidosis.
  • Identify key diagnostic modalities for early detection of cardiac toxicity in cancer patients.
  • Review current therapeutic interventions for carcinoid valvular heart disease.
  • Assess the cardiovascular risk profile of individuals diagnosed with prostate cancer.
  • Recognize unique risk factors for hypertension in cancer patients, including treatment-related factors and comorbidities.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge, or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 19.50 ABIM
  • 19.50 ACPE
  • 19.50 AMA PRA Category 1 Credit
  • 19.50 ANCC
  • 19.50 Attendance
Event starts: 
11/07/2024 - 7:45am
Event ends: 
11/09/2024 - 3:45pm

PDF / Printable Version  

Mayo Clinic Cardio-Oncology Update 2024

Scottsdale, Arizona

November 7, 2024 to November 9, 2024

Mountain Standard Time

 

Day 1

Thursday, November 7, 2024

6:45 AM

Registration, Continental Breakfast & Exhibits

7:45 AM

Welcome and Announcements
 

Session 1: Introduction to Cancer Therapy Related Cardiotoxicity
Moderators: Donald W. Northfelt, M.D. and Lida A. Mina, M.D.

8:00 AM

Traditional Cancer Therapies
Donald W. Northfelt, M.D.

8:30 AM

Targeted Therapies for Breast Cancer
Lida A. Mina, M.D.

9:00 AM

Tyrosine Kinase Inhibitors
Chris Ray, M.D.

9:30 AM

Break

10:00 AM

Cellular Therapies and the Heart (CAR-T)
Javier L. Munoz, M.D., M.B.A.

10:30 AM

Checkpoint Inhibitors
Joerg Herrmann, M.D.

11:00 AM

Introduction to Radiation Therapy
Sameer R. Keole, M.D.

11:30 AM

Q&A Panel
Donald W. Northfelt, M.D., Lida Mina, M.D., Chris Ray, M.D., Javier L. Munoz, M.D., M.B.A., Joerg Herrmann, M.D.,
and Sameer R. Keole, M.D.

12:00 PM

Lunch Break -  Ask a Pharmacist Session
(12:15 - 1:00 PM)

Session 2: Introduction to Cardio-Oncology
Moderator: Carolyn M. Larsen, M.D. and Joerg Herrmann, M.D.

1:00 PM

Guideline Based Surveillance Strategy for Chemotherapy Related Cardiotoxicity: LVEF and Beyond
Hector R. Villarraga, M.D.

1:30 PM

Prevention and Management of Chemotherapy Related Cardiotoxicity
Carolyn M. Larsen, M.D.

2:00 PM

Role for Advanced Heart Failure Therapies in Cardio-Oncology
Brian W. Hardaway, M.D.

2:30 PM

Break

3:00 PM

Role of Advanced Imaging in Cardio-Oncology
Balaji Tamarappoo, M.D.

3:30 PM

Artificial Intelligence: The Future of Risk Stratification and Early Detection of Cardiotoxicity?
Reza Arsanjani, M.D.

4:00 PM

Q&A Panel
Hector R. Villarraga, M.D., Carolyn M. Larsen, M.D.,
Brian W. Hardaway, M.D., Balaji Tamarappoo, M.D.,
and Reza Arsanjani, M.D.

4:30 PM

Break

4:45 PM

ICOS Board Review Questions
(Separate Registration)

Joerg Herrmann, M.D.
and Daniel Lenihan, M.D., FACC, FESC, FIC-OS

6:15 PM

Adjourn

 

Day 2

Friday, November 8, 2024

6:30 AM

Continental Breakfast and Exhibits

7:25 AM

Announcements
Moderators: Chris Ray, M.D.
and Chadi Ayoub, M.B.B.S., Ph.D.

7:30 AM

Keynote Lecture: Top 10 Publications in Cardio-Oncology in the Past Year
Daniel Lenihan, M.D., FACC, FESC, FIC-OS

Session 3: Leukemia and Lymphoma
Moderators: Chris Ray, M.D. and Chadi Ayoub, M.B.B.S., Ph.D.

8:30 AM

Stem Cell Transplant and the Heart
Jeanne M. Palmer, M.D.

9:00 AM

Understanding CHIP (Clonal Hematopoiesis of Indeterminate Potential) and Implications for Cardiovascular Risk
Naveen L. Pereira, M.D.

9:30 AM

Break

10:00 AM

Case Presentation: Atrial Fibrillation and CLL
Chris Ray, M.D.

10:30 AM

Evaluation and Management of Drug Related QTc Prolongation
Hicham El Masry, M.D.

11:00 AM

Guideline Based Management of DVT and PE
Fadi E. Shamoun, M.D.

11:30 AM

Q&A Panel
Jeanne M. Palmer, M.D., Naveen L. Pereira, M.D.,
Chris Ray, M.D., Hicham El Masry, M.D.,
and Fadi E. Shamoun, M.D.

12:00 PM

Lunch - Challenging Audience Cases Session  (12:15 - 1:00 PM)

Session 4: Cardiac Risk of Hormone Therapy
Moderators: Donald W. Northfelt, M.D. and Lida A. Mina, M.D.

1:00 PM

Prostate Cancer and Heart Disease
Parminder Singh, M.D.

1:30 PM

Hormone Therapy and Cardiac Risk in Breast Cancer
Hema Narayanasamy, M.B.B.S.

2:00 PM

Exercise and Cardiac Rehab for Cancer Patients
Regis I. Fernandes, M.D.

2:30 PM

Hypertension Management in Cancer Patients
Sandra M. Herrmann, M.D.

3:00 PM

Q&A Session
Parminder Singh, M.D., Hema Narayanasamy, M.B.B.S., Regis I. Fernandes, M.D., and Sandra M. Herrmann, M.D.

3:30 PM

Break

3:45 PM

ICOS Board Review Questions
(Separate Registration)

Joerg Herrmann, M.D.
and Daniel Lenihan, M.D., FACC, FESC, FIC-OS

5:15 PM

Adjourn

 

Day 3

Saturday, November 9, 2024

6:40 AM

Continental Breakfast and Exhibits

7:40 AM

Announcements

Session 5: Building a Cardio-Oncology Practice
Moderators: Joerg Herrmann, M.D., and Chris Ray, M.D.

7:45 AM

My Experience Building a Cardio-Oncology Practice
Joerg Herrmann, M.D., and Chris Ray, M.D.

8:15 AM

Key Pearls from my Cardio-Oncology Practice: An APP Perspective
Alyssa D. McPherson, APRN, D.N.P.

8:45 AM

Cardiovascular Considerations in Cancer Survivorship
Kathryn J. Ruddy, M.D.

9:15 AM

Break

9:45 AM

Neuroendocrine Tumors
Bassam B. Sonbol, M.D.

10:15 AM

Carcinoid Valvular Heart Disease
Chadi Ayoub, M.B.B.S., Ph.D.

10:45 AM

Malignant Cardiac Masses
Melanie C. Bois, M.D.

11:15 AM

Diagnosis and Management of Pericarditis and Pericardial Effusions in Cancer Patients
S. Allen Luis, M.B.B.S., Ph.D.

11:45 AM

Q&A Panel
Joerg Herrmann, M.D., Chris Ray, M.D.,
Alyssa D. McPherson, APRN, D.N.P.,
Kathryn J. Ruddy, M.D., Bassam B. Sonbol, M.D.,
Chadi Ayoub, M.B.B.S., Ph.D., Melanie C. Bois, M.D.,
and S. Allen Luis, M.B.B.S., Ph.D.

12:15 PM

Lunch - Challenging Audience Cases Session (12:30 - 1:15 PM)

Session 6:  Amyloidosis
Moderators: Julie L. Rosenthal, M.D. and Martha Grogan, M.D.

1:15 PM

Introduction to Cardiac Amyloidosis
Martha Grogan, M.D.

1:45 PM

Novel Treatments for TTR Amyloid
Julie L. Rosenthal, M.D.

2:15 PM

Treatment of AL Amyloid with Cardiac Involvement
Angela Dispenzieri, M.D.

2:45 PM

Challenging Case(s) in Cardiac Amyloid
Carolyn M. Larsen, M.D.

3:15 PM

Q&A Session
Martha Grogan, M.D., Julie L. Rosenthal, M.D.,
Angela Dispenzieri, M.D., and Carolyn M. Larsen, M.D.

3:45 PM

Adjourn

 

Internet Live Activity
89644 street
#85
Scottsdale, AZ 69545
United States


Chadi Ayoub, M.B.B.S., Ph.D.
Joerg Herrmann, M.D.
Carolyn M. Larsen, M.D.
Lida A. Mina, M.D.
Donald W. Northfelt, M.D.
Chris Ray, M.D. 

Mayo Faculty
Luis S. Allen, M.B.B.S., Ph.D.
Reza Arsanjani, M.D.
Melanie C. Bois, M.D.
Angela Dispenzieri, M.D.
Hicham El Masry, M.D.
Regis I. Fernandes, M.D.
Martha Grogan, M.D.
Brian W. Hardaway, M.D.
Sandra M. Herrmann, M.D.
Sameet R. Keole, M.D.
Alyssa D. McPherson, APRN, D.N.P.
Javier L. Munoz, M.D., M.B.A.
Hema Narayanasamy, M.B.B.S.
Jeanne M. Palmer, M.D.
Naveen L. Pereira, M.D.
Julie L. Rosenthal, M.D.
Kathryn J. Ruddy, M.D.
Fadi E. Shamoun, M.D.
Parminder Singh, M.D.
Bassam B. Sonbol, M.D.
David E. Steidley, M.D.
Hector R. Villarraga, M.D.

Guest Faculty
Daniel Lenihan, MD, FACC, FESC, FIC-OS

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 22.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DayCredit
Thursday6.50
Friday6.50
Saturday6.50
IC-OS Board Review3.00



ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 22.50 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity. UAN Number: TBD

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 22.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 22.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College of Physicians and Surgeons of Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 19.50 ABIM
  • 19.50 ACPE
  • 19.50 AMA PRA Category 1 Credit
  • 19.50 ANCC
  • 19.50 Attendance
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$950.00Included
Please login or register to take this course.
$150.00Included
Please login or register to take this course.
Please login or register to take this course.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 


Commitment to Equity, Diversity and Inclusion​ 

Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.  ​ 


Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.